Page last updated: 2024-11-02

pioglitazone and Sclerosis

pioglitazone has been researched along with Sclerosis in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Sclerosis: A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, HC1
Ma, LJ1
Ma, J1
Fogo, AB1

Other Studies

1 other study available for pioglitazone and Sclerosis

ArticleYear
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
    Kidney international, 2006, Volume: 69, Issue:10

    Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Antibiotics, Antineoplastic; Blood Pressure; Bl

2006